4.0 Review

Risk Factors and Cancer Screening in Myositis

Journal

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
Volume 46, Issue 3, Pages 565-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.rdc.2020.05.006

Keywords

Idiopathic inflammatory myopathies; Dermatomyositis; Cancer screening

Categories

Ask authors/readers for more resources

The idiopathic inflammatory myopathies, particularly dermatomyositis, are associated with an increased risk of cancer. Lung, ovarian, breast, colon, prostate, and cervical cancers, and hematologic malignancies, are among the most common associated cancers. Risk stratification for cancer in patients with myositis is based on clinical risk factors/red flags, myositis clinical subtypes, and myositis-specific autoantibodies. Clinical risk factors include older age at disease onset, male gender, dysphagia, acute onset/refractory myositis, cutaneous ulceration, necrosis/vasculitis, and elevated inflammatory markers. Appropriate screening strategies are based on the risk level. Further studies are warranted to determine the role of advanced imaging and comprehensive cancer screening.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available